127 related articles for article (PubMed ID: 8219653)
1. Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?
Jungmann E; Felber A; Graeber S; Hillmann U; Haak T; Palitzsch KD; Usadel KH
Clin Investig; 1993 Aug; 71(8):604-9. PubMed ID: 8219653
[TBL] [Abstract][Full Text] [Related]
2. [The role of human atrial natriuretic peptide on pathogenesis of nephropathy in patients with type I diabetes mellitus].
Jungmann E; Graeber S; Scherberich J; Usadel KH
Med Klin (Munich); 1992 Dec; 87(12):622-5. PubMed ID: 1287423
[TBL] [Abstract][Full Text] [Related]
3. Basal and stimulated plasma atrial natriuretic factor in patients with type 1 diabetes with and without nephropathy.
McKnight JA; Roberts G; Sheridan B; Bell PM; Atkinson AB
Diabet Med; 1991 Oct; 8(8):765-9. PubMed ID: 1838069
[TBL] [Abstract][Full Text] [Related]
4. [What pathophysiologic significance does increased plasma levels of human atrial natriuretic peptide have in patients with diabetes mellitus?].
Jungmann E; Höll E; Konzok C; Fassbinder W; Schöffling K
Z Kardiol; 1988; 77 Suppl 2():114-8. PubMed ID: 2970166
[TBL] [Abstract][Full Text] [Related]
5. Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type 1 diabetes mellitus.
Jungmann E; Seel K; Hofmann E; Scheuermann EH; Schöffling K
Klin Wochenschr; 1989 Dec; 67(23):1174-81. PubMed ID: 2532691
[TBL] [Abstract][Full Text] [Related]
6. [Effect of metabolic control on the renal effects of human atrial natriuretic peptide-(95-126) (urodilatin) in normotensive patients with type I diabetes mellitus].
Jungmann E; Galette A; Hopfenmüller B; Palitzsch KD; Scherberich J; Usadel KH
Med Klin (Munich); 1992 May; 87(5):242-6. PubMed ID: 1319542
[TBL] [Abstract][Full Text] [Related]
7. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic factor in various stages of diabetic nephropathy.
Sawicki PT; Heinemann L; Rave K; Hohmann A; Berger M
J Diabet Complications; 1988; 2(4):207-9. PubMed ID: 2976764
[TBL] [Abstract][Full Text] [Related]
9. Plasma N-terminal pro-brain natriuretic peptide in Type 1 diabetic patients with and without diabetic nephropathy.
Siebenhofer A; Ng LL; Plank J; Berghold A; Hödl R; Pieber TR
Diabet Med; 2003 Jul; 20(7):535-9. PubMed ID: 12823233
[TBL] [Abstract][Full Text] [Related]
10. [Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy].
Sawicki P; Heinemann L; Rave K; Berger M
Z Kardiol; 1988; 77 Suppl 2():111-3. PubMed ID: 2970165
[TBL] [Abstract][Full Text] [Related]
11. Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type 1 diabetes mellitus.
Jungmann E; Walter-Schräder MC; Haak T; Fassbinder W; Wambach G; Althoff PH; Schöffling K
Klin Wochenschr; 1988 Jun; 66(12):527-32. PubMed ID: 2971131
[TBL] [Abstract][Full Text] [Related]
12. Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
Mühlhauser I; Prange K; Sawicki PT; Bender R; Dworschak A; Schaden W; Berger M
Diabetologia; 1996 Feb; 39(2):212-9. PubMed ID: 8635674
[TBL] [Abstract][Full Text] [Related]
13. On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy.
Hommel E; Mathiesen ER; Giese J; Nielsen MD; Schütten HJ; Parving HH
Scand J Clin Lab Invest; 1989 Oct; 49(6):537-44. PubMed ID: 2531916
[TBL] [Abstract][Full Text] [Related]
14. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.
Jaffa AA; Durazo-Arvizu R; Zheng D; Lackland DT; Srikanth S; Garvey WT; Schmaier AH;
Diabetes; 2003 May; 52(5):1215-21. PubMed ID: 12716755
[TBL] [Abstract][Full Text] [Related]
15. Hypertension in diabetes as related to nephropathy. Early blood pressure changes.
Feldt-Rasmussen B; Borch-Johnsen K; Mathiesen ER
Hypertension; 1985; 7(6 Pt 2):II18-20. PubMed ID: 3878333
[TBL] [Abstract][Full Text] [Related]
16. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
Mori K
Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713
[TBL] [Abstract][Full Text] [Related]
17. [Microalbuminuria and tubular reabsorption of minerals in children with type 1 diabetes mellitus].
Sufliarska A; Michalková D; Tomecková E; Sílesová J; Lenková N; Kovács L
Bratisl Lek Listy; 1998 Jan; 99(1):26-32. PubMed ID: 9588076
[TBL] [Abstract][Full Text] [Related]
18. A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study Group.
Schmidt S; Blüthner M; Giessel R; Strojek K; Bergis KH; Grzeszczak W; Ritz E
Nephrol Dial Transplant; 1998 Jul; 13(7):1807-10. PubMed ID: 9681733
[TBL] [Abstract][Full Text] [Related]
19. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
[TBL] [Abstract][Full Text] [Related]
20. The role of hypertension in the development of nephropathy in type 1 (insulin-dependent) diabetes mellitus.
Feldt-Rasmussen B; Nørgaard K; Jensen T; Mathiesen E; Deckert T
Acta Diabetol Lat; 1990; 27(2):173-9. PubMed ID: 2198748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
